Mirae Asset Global Investments Co., Ltd.

Position in APGE — Apogee Therapeutics, Inc.

CIK 1569395 SEOUL, M5

Position in APGE

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$367,529

+$126,803 QoQ

Shares Held

2,769

-3.2% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#218

of 288 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names. APGE ranks #34 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	210,209	$104,417,115
2	REGN	Regeneron Pharmaceuticals, Inc.	93,632	$58,383,296
3	ALNY	Alnylam Pharmaceuticals, Inc.	61,531	$18,522,675
4	MDGL	Madrigal Pharmaceuticals, Inc.	33,420	$17,944,868
5	ARGX	Argenx SE	11,164	$10,357,623
6	ONC	BeOne Medicines Ltd.	33,808	$9,634,265
7	RPRX	Royalty Pharma plc	150,556	$8,441,674
8	INCY	Incyte Corp	63,812	$7,233,728

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$367,529	2,769	-3.2%	Shares	Sole	2026-07-22
2026-03-31	$240,726	2,860	+7.3%	Shares	Sole	2026-05-04
2025-12-31	$201,154	2,665	+49.5%	Shares	Sole	2026-01-26
2025-09-30	$70,838	1,783	+0.2%	Shares	Sole	2025-11-03
2025-06-30	$77,261	1,779	+18.0%	Shares	Sole	2025-07-21
2025-03-31	$56,301	1,507	+0.5%	Shares	Sole	2025-04-24
2024-12-31	$67,950	1,500	-7.9%	Shares	Sole	2025-01-27
2024-09-30	$95,628	1,628	+21.2%	Shares	Sole	2024-10-23
2024-06-30	$52,847	1,343	—	Shares	Sole	2024-07-30
No filing history on record for this holder in this stock.